ATE502302T1 - Verfahren zum nachweis oder zur überwachung einer bösartigen plasmazellkrankheit - Google Patents
Verfahren zum nachweis oder zur überwachung einer bösartigen plasmazellkrankheitInfo
- Publication number
- ATE502302T1 ATE502302T1 AT06703629T AT06703629T ATE502302T1 AT E502302 T1 ATE502302 T1 AT E502302T1 AT 06703629 T AT06703629 T AT 06703629T AT 06703629 T AT06703629 T AT 06703629T AT E502302 T1 ATE502302 T1 AT E502302T1
- Authority
- AT
- Austria
- Prior art keywords
- detecting
- immunoglobulins
- bound
- plasma cell
- cell disease
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 208000021161 Plasma cell disease Diseases 0.000 title abstract 2
- 230000003211 malignant effect Effects 0.000 title abstract 2
- 238000012544 monitoring process Methods 0.000 title abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 7
- 102000018358 immunoglobulin Human genes 0.000 abstract 7
- 229940072221 immunoglobulins Drugs 0.000 abstract 5
- 238000003556 assay Methods 0.000 abstract 1
- 239000011324 bead Substances 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0501741.3A GB0501741D0 (en) | 2005-01-27 | 2005-01-27 | Antibody |
| PCT/GB2006/000267 WO2006079816A1 (en) | 2005-01-27 | 2006-01-26 | Method of detecting or monitoring a malignant plasma cell disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE502302T1 true ATE502302T1 (de) | 2011-04-15 |
Family
ID=34259791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06703629T ATE502302T1 (de) | 2005-01-27 | 2006-01-26 | Verfahren zum nachweis oder zur überwachung einer bösartigen plasmazellkrankheit |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7897353B2 (enExample) |
| EP (2) | EP2306202B1 (enExample) |
| JP (3) | JP5431674B2 (enExample) |
| AT (1) | ATE502302T1 (enExample) |
| DE (1) | DE602006020688D1 (enExample) |
| DK (1) | DK2306202T3 (enExample) |
| ES (2) | ES2365626T7 (enExample) |
| GB (1) | GB0501741D0 (enExample) |
| PL (1) | PL2306202T3 (enExample) |
| PT (1) | PT2306202E (enExample) |
| WO (1) | WO2006079816A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0608444D0 (en) | 2006-04-27 | 2006-06-07 | Binding Site The Ltd | Dialysis |
| GB0801609D0 (en) * | 2008-01-29 | 2008-03-05 | Binding Site The Ltd | Hevylite diagnostic stain |
| SG174992A1 (en) | 2009-04-01 | 2011-11-28 | Genentech Inc | Anti-fcrh5 antibodies and immunoconjugates and methods of use |
| GB0914535D0 (en) * | 2009-08-19 | 2009-09-30 | Binding Site Group The Ltd | Prognosis assay |
| GB201001946D0 (en) * | 2010-02-05 | 2010-03-24 | Binding Site Group The Ltd | Cancer prognostic assay |
| GB201001950D0 (en) * | 2010-02-05 | 2010-03-24 | Binding Site Group The Ltd | Infection prognostic assay |
| GB201012049D0 (en) | 2010-07-19 | 2010-09-01 | Binding Site Group The Ltd | Competition assay |
| GB201203938D0 (en) | 2012-03-06 | 2012-04-18 | Binding Site Group The Ltd | Assay system |
| US9550004B2 (en) | 2013-09-06 | 2017-01-24 | Sensor Electronic Technology, Inc. | Ultraviolet diffusive illumination |
| US10267806B2 (en) | 2014-04-04 | 2019-04-23 | Mayo Foundation For Medical Education And Research | Isotyping immunoglobulins using accurate molecular mass |
| GB201511364D0 (en) * | 2015-06-29 | 2015-08-12 | Binding Site Group The Ltd | Method of detecting or monitoring an IgG4-related disease |
| GB2541027A (en) * | 2015-08-07 | 2017-02-08 | The Binding Site Group Ltd | Treatment |
| US12153052B2 (en) | 2017-09-13 | 2024-11-26 | Mayo Foundation For Medical Education And Research | Identification and monitoring of immunoglobulin J chains |
| US11946937B2 (en) | 2017-09-13 | 2024-04-02 | Mayo Foundation For Medical Education And Research | Identification and monitoring of apoptosis inhibitor of macrophage |
| WO2021202992A2 (en) * | 2020-04-03 | 2021-10-07 | Lawrence Loomis | Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3907502A (en) | 1973-12-11 | 1975-09-23 | Miless L Brink | Method for identifying Bence Jones proteins |
| EP0044219A1 (en) | 1980-07-16 | 1982-01-20 | Unilever Plc | Methods of immuno analysis using monoclonal antibodies |
| JPS63139199A (ja) * | 1986-12-01 | 1988-06-10 | Wakunaga Pharmaceut Co Ltd | 抗ヒトＩｇＥモノクロ−ナル抗体及びその用途 |
| ES2150428T3 (es) | 1987-04-27 | 2000-12-01 | Unilever Nv | Ensayos de union especifica. |
| US4983530A (en) * | 1988-01-29 | 1991-01-08 | E. I. Du Pont De Nemours And Company | Sandwich immunoassay for determination of total monoclonal IGG |
| US5185066A (en) * | 1988-08-11 | 1993-02-09 | Helena Laboratories Corporation | Immunofixation electrophoresis control system |
| JPH03199966A (ja) * | 1989-12-27 | 1991-08-30 | Kazutomo Wakasugi | 遊離型ｌ鎖の測定方法 |
| JPH04262792A (ja) * | 1990-01-12 | 1992-09-18 | Takeda Chem Ind Ltd | 蛋白質の精製法 |
| US5228960A (en) * | 1992-07-17 | 1993-07-20 | Beckman Instruments, Inc. | Analysis of samples by capillary electrophoretic immunosubtraction |
| US5552277A (en) * | 1994-07-19 | 1996-09-03 | The Johns Hopkins University School Of Medicine | Genetic diagnosis of prostate cancer |
| EP0862584B1 (en) | 1995-11-03 | 2004-12-22 | The Binding Site Limited | Production of antibodies |
| GB9718911D0 (en) * | 1997-09-05 | 1997-11-12 | Orion Yhtymae Oy | Monoclonal antibodies |
| ATE301131T1 (de) * | 1998-11-19 | 2005-08-15 | Elan Corp Plc | Gegen gastrointestinale transport rezeptoren gerichtete retro-invertierte peptide und deren verwendung |
| US20040163137A1 (en) * | 2001-02-20 | 2004-08-19 | Caroline Barry | PG-3 and biallelic markers thereof |
| US20020182748A1 (en) | 2001-03-30 | 2002-12-05 | Reardon Paul C. | Method and device for testing for Bence-Jones Protein |
| CA2468950A1 (en) * | 2001-11-27 | 2003-06-05 | Mochida Pharmaceutical Co., Ltd. | Anti-il13 receptor .alpha.1 neutralizing antibody |
| US20040018576A1 (en) * | 2002-07-24 | 2004-01-29 | Dematteo Todd M. | Bence Jones protein testing cassette |
| AU2004210975B2 (en) * | 2003-02-10 | 2008-04-10 | Agensys, Inc. | Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| WO2004073656A2 (en) * | 2003-02-20 | 2004-09-02 | Seattle Genetics, Inc. | Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| JP4473257B2 (ja) * | 2003-04-02 | 2010-06-02 | エフ．ホフマン−ラ ロシュ アーゲー | インスリン様成長因子ｉ受容体に対する抗体及びその使用 |
| JP4286256B2 (ja) * | 2003-11-19 | 2009-06-24 | ヤマサ醤油株式会社 | ベンスジョーンズ蛋白質の検定法 |
| JP4438455B2 (ja) * | 2004-03-04 | 2010-03-24 | ヤマサ醤油株式会社 | 遊離ヒトイムノグロブリン軽鎖の測定法及びキット |
| WO2005116651A2 (en) * | 2004-05-24 | 2005-12-08 | Diasys Corporation | Method and device for testing for bence-jones protein |
-
2005
- 2005-01-27 GB GBGB0501741.3A patent/GB0501741D0/en not_active Ceased
-
2006
- 2006-01-26 ES ES06703629.3T patent/ES2365626T7/es active Active
- 2006-01-26 US US11/883,003 patent/US7897353B2/en active Active
- 2006-01-26 AT AT06703629T patent/ATE502302T1/de not_active IP Right Cessation
- 2006-01-26 EP EP10196249.6A patent/EP2306202B1/en active Active
- 2006-01-26 EP EP06703629.3A patent/EP1842071B3/en active Active
- 2006-01-26 WO PCT/GB2006/000267 patent/WO2006079816A1/en not_active Ceased
- 2006-01-26 PL PL10196249T patent/PL2306202T3/pl unknown
- 2006-01-26 DK DK10196249.6T patent/DK2306202T3/da active
- 2006-01-26 PT PT101962496T patent/PT2306202E/pt unknown
- 2006-01-26 DE DE602006020688T patent/DE602006020688D1/de active Active
- 2006-01-26 JP JP2007552716A patent/JP5431674B2/ja not_active Expired - Fee Related
- 2006-01-26 ES ES10196249.6T patent/ES2455440T3/es active Active
-
2011
- 2011-01-21 US US13/011,135 patent/US8415110B2/en not_active Expired - Fee Related
- 2011-01-21 US US13/011,146 patent/US8592561B2/en active Active
-
2013
- 2013-03-06 JP JP2013044306A patent/JP6007134B2/ja not_active Expired - Fee Related
- 2013-10-25 JP JP2013221946A patent/JP5715671B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP5715671B2 (ja) | 2015-05-13 |
| ES2365626T7 (es) | 2014-06-04 |
| JP2008528995A (ja) | 2008-07-31 |
| EP2306202B1 (en) | 2013-12-18 |
| PT2306202E (pt) | 2014-02-27 |
| WO2006079816A1 (en) | 2006-08-03 |
| DE602006020688D1 (de) | 2011-04-28 |
| US20110177535A1 (en) | 2011-07-21 |
| US20110177977A1 (en) | 2011-07-21 |
| DK2306202T3 (da) | 2014-02-10 |
| EP2306202A1 (en) | 2011-04-06 |
| US8415110B2 (en) | 2013-04-09 |
| US7897353B2 (en) | 2011-03-01 |
| JP6007134B2 (ja) | 2016-10-12 |
| ES2455440T3 (es) | 2014-04-15 |
| GB0501741D0 (en) | 2005-03-02 |
| EP1842071B3 (en) | 2014-02-26 |
| JP2013147499A (ja) | 2013-08-01 |
| PL2306202T3 (pl) | 2014-05-30 |
| EP1842071B1 (en) | 2011-03-16 |
| JP2014025950A (ja) | 2014-02-06 |
| ES2365626T3 (es) | 2011-10-07 |
| EP1842071A1 (en) | 2007-10-10 |
| US20080166742A1 (en) | 2008-07-10 |
| JP5431674B2 (ja) | 2014-03-05 |
| US8592561B2 (en) | 2013-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE502302T1 (de) | Verfahren zum nachweis oder zur überwachung einer bösartigen plasmazellkrankheit | |
| DE60136034D1 (de) | Molekular-Modifikations-Assays | |
| ATE449337T1 (de) | Assay | |
| ATE309393T1 (de) | Verfahren zum qualitativen und/oder quantitativen nachweis von zellen | |
| WO2010049672A3 (en) | Methods and products for measuring free immunoglobulin light chain molecules | |
| DE60334029D1 (de) | Hochempfindliche assays für die pathogendetektion unterverwendung der metallverstärkten fluoreszenz | |
| WO2011056185A3 (en) | Reactivity-dependent and interaction-dependent pcr | |
| WO2009058902A3 (en) | Methods and devices for analyte detection | |
| NZ603492A (en) | Humanized anti-factor d antibodies and uses thereof | |
| NZ603084A (en) | Multiple analysis of blood samples | |
| ATE532830T1 (de) | Langwellige thiolgruppenreaktive fluorophore | |
| ATE522546T1 (de) | Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet | |
| WO2008118558A3 (en) | Improved antibody profiling sensitivity through increased reporter antibody layering | |
| ATE541054T1 (de) | Bio-barcode erkennung für zielmoleküle | |
| BRPI0820885B8 (pt) | "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)". | |
| ATE533052T1 (de) | Reagenzien, kits und verfahren zum nachweis biologischer moleküle mittels energieübertragung von einem aktivierten chemilumineszenzsubstrat auf einen energieakzeptorfarbstoff | |
| ATE519116T1 (de) | Verfahren zur normierung der konzentration von analyten in einer urinprobe | |
| WO2008076367A3 (en) | Polymer-protein substrates for immunosorbent fluorescence assays | |
| WO2010006201A3 (en) | Methods of reducing non-specific interaction in metal nanoparticle assays | |
| WO2009075773A3 (en) | Identification of toxin ligands | |
| ATE519112T1 (de) | Verfahren zum nachweis spezifischer antikörper der immunglobulinklasse g | |
| WO2008081331A3 (en) | Enhancing the level of antibody expression by framework re-engineering | |
| ATE511650T1 (de) | Verfahren zum nachweis von antikörpern einer bestimmten klasse über einen immunkomplex spezifischen antikörper | |
| ATE513215T1 (de) | Monoklonale antikörper, hybridomzellinien, verfahren und kits zum nachweis von phytase | |
| DE60323105D1 (de) | Verfahren zur beseitigung von störungen in immunochromatographischen assays |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |